Stock listing
Natera, Inc.
- Ticker
- Tradegate:45E
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
Latest news from Natera, Inc.
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
Oct 13, 2026
FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay
Oct 9, 2026
Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma
Oct 7, 2026
New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists
Oct 6, 2026